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To determine whether protein kinase C plays a role in the actions of insulin and growth hormone in rat adipocytes, we 
tested the effect of acridine orange, a potent inhibitor of kinase C, on the lipogenic activity of both hormones. This com- 
pound completely inhibited the effects of insulin, growth hormone and phorbol ester 12-myristate 13-acetate, whereas 
9-a&dine carboxylic acid, an analog of acridine orange which does not inhibit kinase C, had no effect. Acridine orange 
did not act through inhibition of hormone binding. These data are consistent with the involvement of kinase C in the 
action of insulin and growth hormone on lipogenesis in rat fat cells. 
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1. INTRODUCTION 
Insulin and, under appropriate conditions [l], 
human growth hormone (hGH) stimulate lipogene- 
sis in isolated rat adipocytes. The maximal 
amplitude of the hGH effect is one-fourth to one- 
sixth of that of insulin and their maximal activities 
are non-additive, suggesting that hGH activates a 
subset of the metabolic pathways stimulated by in- 
sulin [2]. Previous data, including the stimulation 
of lipogenesis by phorbol ester 1Zmyristate 
13-acetate (PMA), suggested to us that protein 
kinase C may be involved in the putative common 
pathway shared by insulin and growth hormone. 
Accordingly, we showed that the effect of PMA on 
lipogenesis was non-additive to the effects of in- 
sulin or hGH and that down-regulation of protein 
kinase C markedly inhibited the effects of both 
hormones [3]. 
To evaluate further the role of kinase C in the 
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action of insulin and growth hormone, we have in- 
vestigated the effect of acridine orange on 
lipogenesis. We report here that this newly de- 
scribed inhibitor of kinase C [4] is also a potent in- 
hibitor of insulin-, growth hormone- and 
PMA-stimulated lipogenesis in rat adipocytes. 
2. MATERIALS AND METHODS 
2.1. Materials 
Human growth hormone (hGH; NIDDK hGH bulk 
2.4 IU/mg) was obtained from the National Hormone and 
Pituitary Program, NIDDK (Dr Raiti, University of Maryland 
School of Medicine). Porcine insulin, bovine serum albumin 
(BSA) fraction V (batch 17F-0149) and phorbol 1Zmyristate 
13-acetate (PMA) were purchased from Sigma (St. Louis, MO), 
D-[3-3H]glucose from DuPont NEN (Boston, MA), collagenase 
(Cls II, batch 67157M) from Cooper Biomedical (Freehold, 
NJ), and acridine orange and 9-acridine carboxylic acid from 
Aldrich (Milwaukee, WI). Other chemicals were of reagent 
grade and were obtained from J.T. Baker Chemical 
(Phillisburg, NJ). ‘251-Ty?‘4-insulin and ‘?-hGH were 
prepared as described in [2]. 
2.2. Animals 
Male Wistar rats (120-140 g) were obtained from Charles 
River (Wilmington, MA) and were maintained in light-dark 
cycles of 12 h and fed ad libitum. 
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2.3. Lipogenesis and binding experiments L 
Preparation of adipocytes, lipogenesis assay and hormone 
binding were performed as in [2]. When used, PMA was 
dissolved (10 mg/ml) in dimethyl sulfoxide prior to dilution in 
lipogenesis buffer. The maximal dimethyl sulfoxide concentra- 
tion used did not modify the cell response in control lipogenesis 
assays. Acridine orange and 9-acridine carboxylic acid were 
first dissolved (1 mM) in distilled water and then diluted in ap- 
propriate buffer. Each experiment was repeated at least three 
times, with comparable results. 
3. RESULTS 
3.1. Effect of acridine orange on stimulated 
lipogenesis in rat adipocytes 
In order to restore the cell sensitivity to growth 
hormone [1,2], rat adipocytes were first prein- 
cubated for 4 h at 37°C without growth hormone 
in lipogenesis buffer prior to lipogenesis assay [2]. 
Fig. 1 shows the effect of acridine orange on the in- 
corporation of tritiated glucose into intracellular 
lipids. The maximal effect of insulin on lipogenesis 
was inhibited in a dose-dependent manner, with a 
half-maximal effective dose of 5-8 PM acridine 
orange. In parallel, increasing concentrations of 
acridine orange progressively inhibited both 
growth hormone- and PMA-stimulated lipogenesis 
as well as basal lipogenesis. Cell viability, as tested 
by the Trypan blue exclusion method, remained 
unchanged in the presence of 100 PM acridine 
orange. 
Fig.1. Effect of acridine orange and 9-acridine carboxylic acid 
on basal or stimulated lipogenesis in preincubated rat 
adipocytes. After 4 h of preincubation at 37°C without 
hormone, cells (4 x l@/tube) were incubated in triplicate for 
2 h at 37°C without (basal) or with a maximally effective dose 
of insulin (10 ng/ml), hGH (1000 ng/ml) or PMA (100 ng/ml) 
and 9 nM D-[3-“HIglucose in the presence of increasing 
concentrations of acridine orange or 9-acridine carboxylic acid. 
Results (means + SD; expressed in cpmkube) are plotted as a 
lipogenesis by more than 85% (fig.2). At 1OOpM 
however, the binding of both hormones was 
decreased by 50%. 
The analog 9-acridine carboxylic acid, inactive 
on kinase C [4], had no inhibitory effect on basal 
or stimulated lipogenesis at concentrations up to 
200 ,uM (fig.1). 
Similar effects of acridine orange and lack of ef- 
fect of 9-acridine carboxylic acid were observed on 
basal and insulin-stimulated lipogenesis in fresh, 
non-preincubated rat adipocytes (not shown). 
3.2. Effect of acridine orange on hormone binding 
to rat adipocytes 
We evaluated whether the inhibitory effect of 
acridine orange on growth hormone and insulin ac- 
tion was due to an inhibition of binding to their 
receptors. The binding experiments were con- 
ducted under conditions as close as possible to 
those used to measure lipogenesis [2]. Fig.2 shows 
that acridine orange had no significant effect on 
insulin and growth hormone binding at concentra- 
tions up to 10 PM which inhibited their effect on 
Fig.2. Effect of acridine orange on hormone binding to rat 
adipocytes. (Left) ‘2sI-TyrA’4-insulin (30000 cpmkube) was 
incubated in duplicate for 45 min at 37°C with isolated 
adipocytes (4 x 10s cells/tube) without (total binding) or with 
10 pg/ml unlabeled insulin (nonspecific binding) in the presence 
of increasing concentrations of acridine orange. (Right) i’sI- 
hGH (50000 cpmkube) was incubated in duplicate for 75 min 
at 37’C with isolated adipocytes (8 x lo5 cells/tube) without 
(total binding) or with lO~g/ml unlabeled hGH (nonspecific 
binding) in the presence of increasing concentration of acridine 
orange. ‘251-hormone binding, expressed in cpm/tube, is 
plotted as a function of acridine orange concentration. 
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4. DISCUSSION 
The involvement of protein kinase C in insulin 
effects in rat adipocytes has been suggested by 
Taken together, our results are consistent with 
the involvement of kinase C in insulin and growth 
hormone action on lipogenesis in fat cells. The fact 
that acridine orange also inhibited basal 
lipogenesis may suggest hat rather than being a 
direct mediator in the mechanisms of action of 
both hormones, kinase C acts as a modulator with 
a permissive effect at a rate-limiting step in the 
pathways used by insulin to stimulate lipogenesis. 
The extracellular glucose concentration in our 
lipogenesis assay is low (0.27 mM) [2] and 
therefore glucose uptake represents an obvious 
limiting step in the incorporation of glucose into 
cellular lipids. Since phorbol esters have a maximal 
effect comparable to that of insulin on the 
translocation of glucose carriers in rat fat cells 
[23], it is tempting to speculate that kinase C exerts 
a permissive effect on glucose transporter 
translocation which is the first step in the stimula- 
tion of glucose transport. 
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several investigators. Indeed, phorbol esters, 
which activate kinase C, mimick the action of 
insulin on phosphorylation of intracellular sub- 
strates, glucose transport, glycolysis and lipogene- 
sis [3,5-111 while kinase C down-regulation sig- 
nificantly decreases insulin effects in these cells 
[3,11]. However, the interactions between phorbol 
esters and insulin are rather complex, since PMA 
also stimulates the phosphorylation of serine and 
threonine residues of the insulin receptor which 
results in inhibition of insulin’s effects [12-151. 
Moreover, unlike PMA, insulin does not induce 
translocation of protein kinase C from the cytosol 
to the membrane during enzyme activation [16] 
and its effectiveness on the breakdown of phos- 
phatidylinositol phosphate generating inositol 
triphosphate and diacylglycerol, the intracellular 
activator of kinase C, remains controversial [17]. 
In an attempt o clarify and to evaluate further the 
potential role of kinase C in the action of insulin 
and growth hormone, we have used here a newly 
described inhibitor of kinase C, acridine orange. 
This compound inhibits kinase C by interacting 
with the regulatory domain of the enzyme in a 
more specific way than inhibitors such as H-7 
which competes for the ATP-binding domain of 
the kinase [ 181. The availability of close structural 
analogs of acridine orange which do not inhibit 
kinase C [4] allows unambiguous negative controls 
in intact cells. Our data showed that insulin- and 
growth hormone-stimulated lipogenesis is in- 
hibited by acridine orange over a concentration 
range lo-times lower than that reported for the in- 
hibition of kinase C in a micellar system in vitro 
[4]. In contrast, 9-acridine carboxylic acid, which 
does not inhibit kinase C [4], had no effect on the 
action of these hormones. The effect of acridine 
orange on insulin- and hGH-stimulated lipogenesis 
cannot be explained by an inhibition of the binding 
of hormones to their receptors, since it had no ef- 
fect on hormone binding at a concentration 
(10 FM) which inhibits most of the lipogenic activi- 
ty of the hormones. These results are in agreement 
with recent reports by our group and others that 
sphingosine, another inhibitor of kinase C, inhibits 
the actions of insulin [19-211 and growth hormone 
([22]; Small and De Meyts, submitted). 
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